Yasheng Pharmaceutical-B (06855.HK) announced that the company was informed by Yang Dajun, the company's executive director and chairman of the board of directors, that on April 5, 2024 and April 8, 2024, he subscribed for a total of 80,000 shares of the company's common shares. The total cost was about HK$1,3662 million. The average price was about HK$17.08 per share, accounting for about 0.028% of the company's total issued share capital on the date of this announcement.
亚盛医药-B(06855.HK)获执行董事兼主席杨大俊增持8万股公司股份
Yasheng Pharmaceutical-B (06855.HK) was increased by 80,000 shares of the company by Executive Director and Chairman Yang Dajun
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.